Prospect: Information for the user
Quetiapina Kern Pharma 200 mg film-coated tablets EFG
Read this prospect carefully before starting to take this medicine,because it contains important information for you.
1.What Quetiapina Kern Pharma is and for what it is used
2.What you need to know before taking Quetiapina Kern Pharma
3.How to take Quetiapina Kern Pharma
4.Adverse effects
5.Storage of Quetiapina Kern Pharma
6.Contents of the package and additional information
Quetiapina Kern Pharma contains a substance called quetiapine. It belongs to a group of medications called antipsychotics.Quetiapina Kern Pharmamay be used to treat various illnesses, such as:
Your doctor may continue prescribingQuetiapina Kern Pharmaeven when you are feeling better.
Do not take Quetiapina Kern Pharma.
Do not take Quetiapina Kern Pharma if the above applies to you.If you have any doubts, consult your doctor or pharmacist before taking Quetiapina Kern Pharma.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Quetiapina Kern Pharma if:
Inform your doctor immediately if after taking Quetiapina Kern Pharma you experience any of the following::
These conditions may be caused by this type of medication.
Inform your doctor as soon as possible if you have:
Thoughts of suicide and worsening of depression
If you are depressed, you may sometimes think about harming yourself or committing suicide. This may increase at the beginning of treatment, as all these medications take time to take effect, usually around two weeks but sometimes longer. These thoughts may also increase if you stop taking your medication abruptly. You may be more likely to think this way if you are a young adult. Information from clinical trials has shown an increased risk of thoughts of suicide and/or suicidal behavior in young adults under 25 with depression.
If you ever think about harming yourself or committing suicide, contact your doctor or go to the hospital immediately. It may help to tell a close family member or friend that you are depressed, and ask them to read this leaflet. You may ask them to tell you if they think your depression is getting worse, or if they are concerned about changes in your behavior.
Weight gain
Weight gain has been observed in patients taking quetiapine. You and your doctor should monitor your weight regularly.
Children and adolescents
Quetiapina Kern Pharma should not be used in children and adolescents under 18 years of age.
Use of Quetiapina Kern Pharma with other medications
Inform your doctor if you are taking, have taken recently, or may need to take any other medication.
Do not take Quetiapina Kern Pharma if you are using any of the following medications:
Inform your doctor if you are using any of the following medications:
Before stopping any of your medications, consult your doctor first.
Taking Quetiapina Kern Pharma with food, drinks, and alcohol
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication. Do not take Quetiapina Kern Pharma during pregnancy, unless you have consulted your doctor. Do not use Quetiapina Kern Pharma if you are breastfeeding.
The following symptoms, which may represent withdrawal syndrome, may appear in newborns of mothers who have used quetiapine in the last trimester (last three months of pregnancy): tremor, muscle stiffness, and/or weakness, drowsiness, agitation, respiratory problems, and difficulty feeding. If your newborn develops any of these symptoms, you may need to contact your doctor.
Driving and operating machinery
These tablets may make you feel drowsy. Do not drive or operate tools or machinery until you know how the tablets affect you.
Quetiapina Kern Pharma contains lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Effect on drug detection tests in urine
If you are undergoing a drug detection test in urine, taking quetiapine may produce positive results for methadone or certain antidepressant medications known as tricyclic antidepressants (TCAs) when using some analysis methods, although you may not be taking methadone or TCAs. If this occurs, a more specific test may be performed.
Follow exactly the administration instructions of this medication as indicated by your doctor. In case of doubt, consult your doctor or pharmacist again. Your doctor will decide your initial dose. The maintenance dose (daily dose) will depend on your illness and your needs, but it will normally be between 150 mg and 800 mg.
Liver problems
If you have liver problems, your doctor may change your dose.
Older adults
If you are an older adult, your doctor may change your dose.
Use in children and adolescents
Quetiapina Kern Pharmashould not be used inchildren and adolescentsunder 18 years of age.
If you take more Quetiapina Kern Pharma than you should
If you take moreQuetiapina Kern Pharmathan your doctor prescribed, you mayfeel drowsy, feel dizzy, and experience abnormal heartbeats.Immediately contact your doctor or the nearest hospital. Bring yourQuetiapina Kern Pharmatablets with you.
You can also call the Toxicological Information Service, Phone: 915620420, indicating the medication and the amount taken.
If you forgot to take Quetiapina Kern Pharma
If you forget to take a dose, take it as soon as you remember. If it is almost time for your next dose, wait until then. Do not take a double dose to make up for the missed tablet.
If you interrupt treatment with Quetiapina Kern Pharma
If you stop takingQuetiapina Kern Pharmaabruptly, you may be unable to sleep (insomnia), or you may feel nausea, or you may experience headaches, diarrhea, vomiting, dizziness, or irritability. Your doctor may suggest reducing the dose gradually before stopping treatment.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Very rare side effects (may affect up to 1 in 10,000 people):
Not known (the frequency cannot be estimated from the available data):
The class of medicines to which Quetiapina Kern Pharma belongs may cause heart rhythm problems that can be serious and, in severe cases, fatal.
Some side effects are only seen when a blood test is done. These include changes in the amount of certain fats (triglycerides and total cholesterol) or sugar in the blood, changes in the amount of thyroid hormones in the blood, increased liver enzymes, decreased numbers of certain types of blood cells, decreased red blood cell count, increased creatine-phosphocinase in the blood (a substance found in muscles), decreased sodium levels in the blood, and increased levels of prolactin hormone in the blood. Increases in prolactin hormone may, in rare cases, lead to the following:
Your doctor may ask you to have blood tests from time to time.
Side effects in children and adolescents
The same side effects that may occur in adults may also occur in children and adolescents.
The following side effects have been observed more frequently in children and adolescents or have not been observed in adults:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children
Do not usethis medicationafter the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
No special storage conditions are required.
Medications should not be disposed of through drains or in the trash. Dispose of packaging and medications you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Quetiapina Kern Pharma
The active ingredient is quetiapine. The tablets contain 200 mg of quetiapine (as quetiapine fumarate).
The other components are:
Tablet core: Lactose monohydrate (lactose), microcrystalline cellulose, calcium dihydroxide phosphate dihydrate, povidone K30, sodium carboxymethyl starch (potato starch) (Type A) and calcium stearate.
Tablet coating: Hypromellose, titanium dioxide (E171) and triacetin.
AppearanceofQuetiapina Kern Pharmaand contents of the packaging
The tablets are white, round and oblong.
They are presented in PVC/aluminum blisters, in packs of 60 tablets.
Holder of the marketing authorizationand responsible for manufacturing
Holder of the marketing authorization
Kern Pharma, S.L.
Venus, 72 - Pol. Ind.Colón II
08228 Terrassa-Barcelona
Spain
Responsible for manufacturing
Laboratorios AlterS.A
Mateo Inurria, 30
28036 Madrid
Date of the last review of thisleaflet:June 2024
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.